U.S. Health and Human Services Secretary Xavier Becerra said today that the 340B program “doesn’t have the transparency we need” and “we are going to do what we can to make it more transparent.”
Becerra was asked about the drug discount program this morning during a House Energy & Commerce health subcommittee hearing on HHS’s fiscal year 2024 budget request. Subcommittee Vice Chair Larry Bucshon (R-Ind.) asked Becerra about his antitrust suit against Sutter Health, California’s largest health system, when Becerra was California attorney general. Becerra alleged that Sutter illegally used its dominant position in the northern California health care market to buy competing hospitals and physician practices and raise prices. Sutter settled the suit in 2021 for $575 million and agreed to change its business practices.
U.S. Health and Human Services Secretary Xavier Becerra said today that the 340B program “doesn’t have the transparency we need” and “we are going to do what we can to make it more transparent.” Becerra was asked about the drug […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
